Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
K24 Pharmaceuticals is a Kenyan-based pharmaceutical company that specializes in the marketing, sales, and distribution of high-quality generic medicines. Headquartered in Nairobi, the company focuses on providing affordable healthcare solutions across East Africa, including Kenya, Uganda, and Tanzania. Their product portfolio covers a wide range of therapeutic areas such as anti-infectives, cardiology, gastroenterology, and pain management. K24 Pharmaceuticals partners with international manufacturers that adhere to global quality standards like WHO-GMP to ensure the safety and efficacy of their products. The company plays a vital role in the regional healthcare ecosystem by bridging the gap between global pharmaceutical production and local patient needs through robust supply chain and regulatory expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on K24 Pharmaceuticals.